Heart Test Laboratories, Inc. (NASDAQ:HSCS) Sees Significant Increase in Short Interest

Heart Test Laboratories, Inc. (NASDAQ:HSCS) was the target of a significant increase in short interest in the month of October. As of October 31st, there was short interest totalling 23,100 shares, an increase of 12.1% from the October 15th total of 20,600 shares. Based on an average daily volume of 357,000 shares, the short-interest ratio is presently 0.1 days. Currently, 2.8% of the shares of the company are sold short.

Wall Street Analyst Weigh In

Separately, Ascendiant Capital Markets reaffirmed a “buy” rating and issued a $15.00 price target on shares of Heart Test Laboratories in a report on Monday, September 23rd.

Heart Test Laboratories Price Performance

NASDAQ HSCS traded up $0.02 during trading hours on Monday, reaching $2.61. 35,420 shares of the stock traded hands, compared to its average volume of 140,040. The company has a market cap of $2.38 million, a price-to-earnings ratio of -0.12 and a beta of 3.27. The stock has a 50 day simple moving average of $3.40 and a two-hundred day simple moving average of $4.43. The company has a debt-to-equity ratio of 0.08, a current ratio of 4.49 and a quick ratio of 4.02. Heart Test Laboratories has a 1 year low of $2.36 and a 1 year high of $29.00.

Heart Test Laboratories (NASDAQ:HSCS) last posted its earnings results on Thursday, September 12th. The company reported ($2.64) earnings per share (EPS) for the quarter. On average, analysts predict that Heart Test Laboratories will post -9.82 EPS for the current fiscal year.

Heart Test Laboratories Company Profile

Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals.